Maintenance Notice (4:30 AM - 11:00 AM December 21, 2024): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 989-51-5 | Product Number: E0694
(-)-Epigallocatechin Gallate Hydrate
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- EGCG Hydrate
- (-)-cis-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-1(2H)-benzopyran-3-yl Gallate Hydrate
Product Documents:
| Size | Unit Price | Belgium | Japan* |
|---|---|---|---|
| 100MG |
€41.00
|
5 | ≥100 |
| 500MG |
€131.00
|
2 | ≥40 |
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | E0694 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__2__2H__1__8O__1__1·xH__2O = 458.38 (as Anhydrous) |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Light Sensitive,Air Sensitive |
| Packaging and Container | 100MG-Glass Bottle with Plastic Insert (View image), 500MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 989-51-5 |
| Related CAS RN | 1257-08-5 |
| Reaxys Registry Number | 67944 |
| PubChem Substance ID | 87558853 |
| Merck Index (14) | 3526 |
| MDL Number | MFCD00075940 |
Specifications
| Appearance | White to Light yellow to Light orange powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Specific rotation [a]20/D | -165.0 to -186.0 deg(C=1, EtOH) |
| Water | max. 5.0 % |
Properties (reference)
| Melting Point | 212 °C |
| Specific Rotation | -176° (C=1,EtOH) |
| Solubility (soluble in) | Ethanol |
GHS
Related Laws:
| RTECS# | KB5200000 |
Transport Information:
| HS Number | 2932990090 |
Application
Type III secretion system (T3SS) research / Type III secretion system (T3SS) inhibitor
References
- Epigallocatechin gallate inhibits the type III secretion system of Gram-negative enteropathogenic bacteria under model conditions
- Epigallocatechin-3-gallate inhibits bacterial virulence and invasion of host cells
Application
(-)-Epigallocatechin Gallate (EGCG): A Polyphenolic Compound with Diverse Biological Activities including Anti-Cancer Effects
(-)-Epigallocatechin gallate (EGCG), a polyphenolic compound, is the ester of epigallocatechin [E1084] and gallic acid [G0011]. EGCG has been found in a variety of plants including green and black tea plants, and reported to have diverse biological activities including antioxidant, anti-cancer, anti-angiogenic and cardiovascular protective effects. (The product is for research purpose only.)
References
- Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions (a review)
- Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications (a review)
- Green tea and its anti-angiogenesis effects (a review)
- Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review
- Molecular understanding of Epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases (a review)
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.